The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(6-(4-(2-((4-methyl-3-(trifluoromethyl)phenyl)amino)-2-oxoethyl)phenyl)-1H-indazol-3-yl)cyclopropanecarboxamide ID: ALA4877128
PubChem CID: 164629152
Max Phase: Preclinical
Molecular Formula: C27H23F3N4O2
Molecular Weight: 492.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(NC(=O)Cc2ccc(-c3ccc4c(NC(=O)C5CC5)n[nH]c4c3)cc2)cc1C(F)(F)F
Standard InChI: InChI=1S/C27H23F3N4O2/c1-15-2-10-20(14-22(15)27(28,29)30)31-24(35)12-16-3-5-17(6-4-16)19-9-11-21-23(13-19)33-34-25(21)32-26(36)18-7-8-18/h2-6,9-11,13-14,18H,7-8,12H2,1H3,(H,31,35)(H2,32,33,34,36)
Standard InChI Key: CTAVSLQHBNDMQA-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
27.7716 -4.4825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9530 -6.1316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6626 -5.7222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6598 -4.8995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9512 -4.4942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2449 -5.7226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2461 -4.9061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4699 -4.6526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9889 -5.3125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.4680 -5.9737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2143 -6.7506 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.3618 -4.4864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7602 -7.3587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5065 -8.1355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5598 -7.1899 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9006 -8.6805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6774 -8.9342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0694 -4.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7646 -3.6639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0509 -3.2627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3523 -3.6774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4682 -3.2483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1800 -3.6498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8836 -3.2342 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.1881 -4.4670 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8999 -4.8685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9030 -5.6843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6139 -6.0857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3185 -5.6700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3077 -4.8487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5962 -4.4509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0308 -6.0706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6217 -6.9029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9179 -7.3182 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
31.3333 -7.3047 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.6158 -7.7179 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 7 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
10 11 1 0
4 12 1 0
11 13 1 0
13 14 1 0
13 15 2 0
16 14 1 0
17 16 1 0
14 17 1 0
12 18 2 0
18 1 1 0
1 19 2 0
19 20 1 0
20 21 2 0
21 12 1 0
19 22 1 0
22 23 1 0
23 24 2 0
23 25 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
29 32 1 0
28 33 1 0
33 34 1 0
33 35 1 0
33 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 492.50Molecular Weight (Monoisotopic): 492.1773AlogP: 6.09#Rotatable Bonds: 6Polar Surface Area: 86.88Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.09CX Basic pKa: 0.74CX LogP: 6.02CX LogD: 6.02Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.30Np Likeness Score: -1.55
References 1. Wang XR, Wang S, Li WB, Xu KY, Qiao XP, Jing XL, Wang ZX, Yang CJ, Chen SW.. (2021) Design, synthesis and biological evaluation of novel 2-(4-(1H-indazol-6-yl)-1H-pyrazol-1-yl)acetamide derivatives as potent VEGFR-2 inhibitors., 213 [PMID:33493829 ] [10.1016/j.ejmech.2021.113192 ]